News Articles and Montana BioScience Alliance Newsletters

Working every day with your best friend would be a dream come true for some people. Getting to work with your best friend to provide a vital service to your hometown community would make it even more special. For University of Montana alums Stacy Conrow-Ververis and Laurel Chambers that dream is a reality.

Opio Connect, Inc., a technology company dedicated to helping Opioid Treatment Programs (OTPs) expand access to treatment, has received a $1.5 million award from the National Institute of Drug Abuse (NIDA), a division of the National Institutes of Health (NIH). 

With a new $26.7 million grant from the U.S. Air Force, Montana State University will establish a facility with the mission of moving advanced quantum technology applications in cybersecurity, communications technology and national defense from concept and testing to market.

With new funding from the U.S. National Science Foundation, research conducted at Montana State University will have more opportunities to be translated into products and solutions with extended real-life impact. MSU was announced last week as one of 18 teams nationwide to receive funding through the NSF’s new Accelerating Research Translation, or ART, program. The cooperative agreement will provide $6 million in support over the next four years.

The University of Montana recently earned a four-year, $4 million Research Evaluation and Commercialization Hub (REACH) award from the National Institutes of Health. The award will establish the L.S. Skaggs Institute for Health Innovation–Research Evaluation and Commercialization Hub (SIHI-REACH).

When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.

Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR

Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.

View the Spring 2024 Newsletter now!

View the Winter II 2024 Newsletter now!